Whitepapers

Mapping new pathways in orphan drug development: Data,
design, and equity

This whitepaper brings together insights from leaders across biotech, pharma, and advocacy to spotlight strategies for accelerating rare disease research. 

The future of precision medicine in autoimmune and inflammatory disease: A strategic framework

This whitepaper outlines a strategic roadmap for delivering precision medicine in autoimmune and inflammatory disease. It explores the tools, infrastructure, and cross-sector collaboration needed to overcome clinical heterogeneity, accelerate therapeutic development, and support equitable access to care.

Scaling patient engagement strategies in precision medicine trials: Technology, integration and regulatory development

This whitepaper explores the solutions and approaches industry experts are developing to successfully scale the use of patient engagement strategies and make the integration of precision medicine into healthcare a global reality. 

The future of hearing: Gene therapy and precision medicine for hearing loss

This whitepaper looks at how precision medicine and gene therapy are changing the way we diagnose and treat genetic hearing loss. It also dives into the challenges, like making these treatments more affordable and accessible.

Conversion vs. compliance: Balancing patient centricity with regulatory restrictions

This whitepaper explores why compliance and conversion don’t need to be in tension and how building a patient-centric approach to trial recruitment leads to improved data quality, and streamlined, highly compliant workflows.

Scaling precision medicine with limited budgets: Practical solutions for biotechs 

This whitepaper provides practical strategies for biotechs to overcome financial constraints, leverage cutting-edge tools, and streamline clinical trials.

Gene and cell therapies in rare diseases: Aligning innovation with patient needs 

This whitepaper examines how patient-focused strategies and advancements in genetic research are improving the effectiveness and accessibility of rare disease treatments.

Precision patient finding: The key to speed, savings, and trial success in biotech

This whitepaper explores how precision patient finding works and why it matters—showing how smarter approaches can reduce screening costs, speed up enrollment, and improve the overall trial experience for patients and researchers alike.

Precision medicine’s promise for better brain health outcomes
How genetic insights and advanced technologies are driving personalized neurological care

This whitepaper dives into the fundamentals of precision neurology, highlighting how breakthroughs in biomarkers, genomic sequencing, and pharmacogenomics are transforming patient care.

Genetics in focus: Addressing the complexities of genetic eye disease and patient care

This whitepaper, developed in partnership with 20/20 Onsite and Clinical Enrollment, provides an in-depth look at the latest breakthroughs in genetic eye disease research, the transformative effects of new therapies on patient care, and the critical role that cross-disciplinary collaborations play in advancing this field.

Global market expansion and the future of precision medicine: The case for internationalization

This whitepaper explores how global strategies are shaping the future of healthcare and creating opportunities in emerging markets.

The importance of genetic testing as a public health initiative: A strategic approach to integration and global collaboration

This whitepaper discusses the role of genetic testing as a public health initiative and provides a comprehensive exploration of how sequencing can be effectively incorporated into public health strategies.

From policy to practise: Integrating precision medicine into healthcare systems

This whitepaper explores the current and emerging policy frameworks that underpin the development of precision medicine in the UK and US. 

Genomic insights into at-risk populations: Strategies for early detection and prevention

This whitepaper explores what the latest innovations and technologies in genomics could mean for the future of early detection and prevention for at-risk populations.

Foundations of clinical innovation: How insights from natural history studies drive drug development

This whitepaper explores how natural history studies propel new drug development, especially in rare disease, maps out the FDA's guidance in this area, and discusses future directions for this type of research.

Newborn genome sequencing: Changing the face of paediatric healthcare

This whitepaper spotlights genomic sequencing's role in pioneering personalised medicine from birth, showcasing its capacity to transform healthcare.

Sano's privacy promise

In this whitepaper, we share the rigorous privacy standards and ethical commitments that underpin our operations. 

Bridging genes and medicine: 
How genetics is redefining healthcare

The whitepaper examines how the adoption of genetic information is changing clinical practice by requiring a more personalised approach to healthcare. 

Beyond the bench: 
The role of patient empowerment in shaping precision medicine research

The whitepaper explores how patient involvement is transforming the field of genomics- and biomarker-driven research. 

Progress through collaboration: Bridging academia, biotech, and pharma in genomic drug development

The whitepaper examines the dynamic interplay between these critical sectors, outlining the path to innovative treatments and reshaping patient care.

Data-driven healthcare: How artificial intelligence and machine learning are transforming genomics

The whitepaper provides an overview of AI's role in genomics and healthcare, discusses AI-driven genomic analysis and patient outcome prediction, and addresses the challenges and ethical considerations of integrating AI into genomics. 

Inclusive genomics: A path to equitable precision medicine

In this whitepaper, we delve into the critical role of diversity, equity, and inclusion (DEI) in genomic research, addressing how these principles not only enhance scientific rigour but also ensure equitable health benefits.

Precision in practice: Harnessing polygenic risk scores for targeted metabolic dysfunction-associated steatohepatitis (MASH) therapies

In this whitepaper, we explore how polygenic risk scores can be harnessed to drive decision-making in MASH management, offering new avenues for early prediction, precise diagnosis, and tailored treatment strategies. 

Strategic approaches for building effective clinical trial recruitment channels 

This whitepaper explores proven recruitment strategies, meaningful measurement, diversity enhancement, and the utilisation of new technologies to ensure efficient and forward-looking recruitment efforts.

Connecting communities: Engaging patients in registries for long-term impact

This whitepaper maps a path for patient advocacy groups looking to engage their communities through sustainable patient registries.   

Unravelling the complexities of genomics-driven drug discovery

Genetics essentials for clinical research professionals

Trial-enabling protocols for precision medicine clinical development teams

The lasting impact of COVID-19 on clinical trials